Market Research Report: Torrent Pharmaceuticals Ltd.
Company Overview
- Name: Torrent Pharmaceuticals Ltd.
- Mission: Commit to total customer care by delivering world-class products and services.
- Vision: To become the most respected Pharma Company.
- Founded: The company was founded in the early '70s.
- Founder: Late Shri U N Mehta.
- Key People:
- Chairman: Mr. Samir Mehta
- Chairman Emeritus: Mr. Sudhir Mehta
- Board of Directors: Includes Ms. Nayantara Bali, Dr. Maurice Chagnaud, Mr. Manish Choksi, Mr. Nikhil Khattau, Mr. Aman Mehta, Mr. Jinal Mehta, and Ms. Ameera Shah
- Headquarters: Torrent House, Off. Ashram Road, Ahmedabad - 380009, Gujarat, India.
- Number of Employees: No information is available.
- Revenue: Rs 10,700 crores (FY2024).
- Known For: Leading company in therapeutic segments of cardiovascular (CV), central nervous system (CNS), gastro-intestinal (GI), women healthcare (WHC), Vitamins Minerals Nutritionals (VMN), and Cosmo-Dermatology. It has a vast presence in diabetology, pain management, gynecology, oncology, and anti-infective segments.
Products
Therapeutic Areas
- Gastro Intestinal
- Neuro-Psychiatric
- Gynecology
- Nephrology
- Oncology
- Anti-Microbial
- Cardiovascular
- Dermatologic
- Urology
- Pain
- Anti-Diabetic
- Other segments such as Vitamins Minerals Nutritionals (VMN) and Miscellaneous
Consumer Healthcare Brands
- Ahaglow: Face wash gel with dermatologically proven formulas.
- Shelcal: A range of calcium supplements.
- Tedibar: A bathing bar offering gentle cleansing.
- Unienzyme: Digestive aid.
- Atogla: Moisturizing lotion with ceramides and oat lipids.
- Spoo: Anti Seborrheic Shampoo.
Product Registrations
- No specific number of product registrations is available.
Manufacturing Plants
- Indrad
- Dahej
- Baddi
- Sikkim Unit I & II
- Sikkim Unit III
- Vizag
- Pithampur
- Bileshwarpura
Recent Developments
- Acquisitions:
- Acquisition of Elder Pharma's Indian branded business in 2014.
- Acquisition of Zyg Pharma's dermaceutical business in 2015.
- Purchased the API plant of Glochem Industries in 2016.
- Acquired Novartis' Women Healthcare brands and Unichem's Indian branded business in 2017.
- Acquisition of Curatio in 2022.
- Sustainability and Environment Commitment:
- Torrent Pharma has committed to significant targets for reducing its greenhouse gas emissions.
- Investment in a Hybrid Solar-Wind project to meet captive power requirements and reduce carbon footprints.
- International Reach:
- Significant presence in over 50 countries, with notable market share in Brazil and Germany.
- Major business segregations in the US, UK, Germany, Europe, Brazil, and the rest of the world.
- Noteworthy Initiatives:
- Contribution of Rs. 100 crores to India's fight against the COVID-19 pandemic, inclusive of support to PM-CARES Fund, essential medicines, and PPE provision.
Conclusion
Torrent Pharmaceuticals Ltd. has established itself as a leader in the pharmaceutical industry, known for diverse therapeutic product offerings and strong international presence. Their strategic acquisitions and commitment to sustainable practices reflect their forward-thinking leadership and mission of delivering world-class healthcare products.
